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The Nef protein of the primate lentiviruses, including human immunodeficiency virus type 1 (HIV-1) and simian immuno-
deficiency virus (SIV), is a myristylated protein associated with increased viral replication and enhanced pathogenicity. Both
the potentiation of T-lymphocyte activation and the enhanced serine-phosphorylation of HIV-1 capsid by Nef correlate with
increased viral replication. We report the functional interactions of the Nef proteins with Src kinases. The Nef proteins from
HIV-1 and SIV bind to Lck as well as Hck, Lyn, and Fyn. The SH3 and SH2 domains of Lck are sufficient for coprecipitation
with non-tyrosine-phosphorylated Nef proteins. The conserved core region of HIV-1 Nef is essential for the interaction with
Lck and is also important for enhanced HIV-1 replication in T-lymphocytes. In addition, we show that SIV and HIV-1 Nef
proteins are differentially tyrosine-phosphorylated. The kinase-active Lck tyrosine-phosphorylates SIVmac239 Nef but does
not phosphorylate HIV-1 Nef. These data suggest that the association of Nef and Lck is central to the enhanced viral
replication of HIV-1 and SIV in T-lymphocytes. © 1999 Academic Press
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Primate lentiviruses possess two characteristics cen-
ral to the understanding of the role of accessory genes
ike nef. One characteristic is that this retroviral subfam-
ly can infect and replicate in nondividing cells; second,
he family is both T-lymphocyte and macrophage tropic.
hus a model of functions of these accessory genes
hould account for these characteristics. nef RNA is the
ajor species of human immunodeficiency virus type 1
HIV-1) viral mRNA expressed immediately postintegra-
ion of the provirus (Cullen, 1991; Robert-Guroff et al.,
990). Despite several intriguing biological characteris-
ics of the Nef proteins, their functions are incompletely
nderstood as they affect both viral replication and
athogenicity (reviewed in Rater et al., 1995; Trono, 1995).
eletion of the nef gene results in a decreased rate of
IV-1 replication in vivo and, in the case of simian im-
unodeficiency virus (SIV), decreases virulence
Chakrabarti et al., 1996; Kestler et al., 1991; Novembre et
l., 1996). Furthermore, an intact nef gene is necessary
or HIV-1 replication in quiescent T-lymphocytes or
onocytes (Miller et al., 1994; Spina et al., 1994). Nef
nteracts with cellular factors of the signal transduction
athways and alters T-lymphocyte activation, as well as
ffecting viral replication in quiescent T-lymphocytes or
1 To whom reprint requests should be addressed at Department of
ediatrics, 550 First Avenue, RM TH-501A. Fax: (212) 263-8172. E-mail:
arksw01@ mcrcr.med.nyu.edu.
5onocytes (Miller et al., 1994; Ratner et al., 1995; Spina et
l., 1994). Nef has been shown to down-regulate the
urface expression of CD4 (Ratner et al., 1995; Trono,
995) and MHC I (Collins et al., 1998).
Several observations suggest that the enhanced viral
eplication by Nef could be related to its ability to pro-
ote T-lymphocyte activation and proliferation (Baur et
l., 1994; Du et al., 1996; Hanna et al., 1998; Skowronski
t al., 1993). It has been shown that both HIV-1 Nef and
IVmac239 Nef enhanced SIV viral replication in an in-
erleukin (IL)-2-dependent rhesus monkey T-lymphocyte
ine in the absence of exogenous IL-2 and, also, in-
reased IL-2 production (Alexander et al., 1997). Alex-
nder et al. (1997)also reported that v-Ras but not c-Ras
eplaced the Nef function (Alexander et al., 1997), sup-
orting the hypothesis that Nef increases viral replication
hrough potentiation of T-lymphocyte signaling pathways.
ther potential mechanisms of Nef-enhanced replication
nclude enhancement of virus infectivity, facilitation of
everse transcription of viral RNA genome, and stimula-
ion of proviral DNA synthesis (Aiken et al., 1995; Chow-
rs et al., 1994; Miller et al., 1994; Spina et al., 1994).
hese effects may be caused by increased serine-phos-
horylation of the HIV-1 matrix protein induced by Nef
Swingler et al., 1997), because the phosphorylation of
IV-1 matrix at serine residues is required for the virus
nfectivity (Bukrinskaya et al., 1996; Gallay et al., 1995).
ef-associated cellular serine kinases have been sug-
ested to mediate this effect (Baur et al., 1997).Although the mechanism of potentiating cellular func-
0042-6822/99 $30.00
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6 CHENG, HOXIE, AND PARKSions by Nef remains to be elucidated, this function may
e associated with Nef’s ability to interact with Src family
inases in T-lymphocytes and macrophages. At least
hree Src family tyrosine kinases, including Hck, Lyn, and
ck, have been documented to associate with Nef (Baur
t al., 1997; Collette et al., 1996; Greenway et al., 1996;
aksela et al., 1995). HIV-1 Nef binds to Hck through its
onserved proline-rich motif (PXXP repeat) and in-
reases its kinase activity (Lee et al., 1995, 1996; Moarefi
t al., 1997; Saksela et al., 1995). The interaction of Nef
nd Lck appears to be controversial. Using the same
onditions that are optimal for the interaction of Nef and
ck, the association of Nef with Lck was not detected
Moarefi et al., 1997; Saksela et al., 1995). Greenway et al.
1996) and Collette et al. (1996) found the PXXP motif of
ef directly interacts with Lck; HIV-1 Nef inhibited the
inase activity of Lck. In contrast, Baur et al. (1997)
bserved that the Nef–Lck association is bridged by a
ellular serine kinase and that Nef’s N-terminal a-helix
omain is sufficient for formation of the complex.
In an attempt to clarify the potential functional linkages
f Nef with Src kinases, particularly Lck, we reassessed
tructural and functional motifs of the Nef proteins de-
ived from both HIV-1 and SIV necessary for the associ-
tion with Src kinases. We found that both Nef proteins
hysically interact with Lck independent of the PXXP
otif in addition to the binding to Hck, Lyn, and Fyn in
ivo. The conserved core of Nef is associated with the
H3 and SH2 domains of Lck; only SIV Nef is tyrosine-
hosphorylated by Lck. We also showed that the core
egion of HIV-1 Nef is essential for enhanced HIV-1
eplication in T-lymphocytes.
RESULTS
he Nef proteins were expressed in potentially
iological active forms
The Nef protein contains an N-terminal myristylation
eptide that is required for plasma membrane attach-
ent. Nef is also localized in cellular compartments,
ncluding cytoplasm and nucleus, and is present in
onmembrane fraction (Kienzle et al., 1992; Murti et al.,
993; Ranki et al., 1994). To determine the relative
mportance of the myristylation or the membrane as-
ociation for the biological activities of Nef, we used
everal approaches to express native Nef protein, as
ell as to express membrane-targeted Nef, using dif-
erent artificial membrane-targeting signal peptides
depicted in Fig. 1A). First, the native nef genes were
onstructed to express a 34-kDa (SIVmac239 Nef) or a
7-kDa (HIV-1 Nef) protein in transiently transfected
93T cells (Fig. 1B). Second, a well-characterized Src
yristylation signal peptide (MYR) was added to the
-terminus of Nef (MYR-Nef) to facilitate Nef’s mem-
rane attachment (Aronheim et al., 1994; Resh, 1994). lhe MYR-Nef protein is presumably processed in the
ame intracellular compartment as the native Nef pro-
ein. Third, we constructed a myristylation-deficient
embrane-targeted Nef (MF-Nef; depicted in Fig. 1A).
F-Nef was created by fusion of the nef gene with
ragments sequentially encoding a preprotrypsin se-
retory leader, an extracellular Flag epitope tag, and
n artificial transmembrane domain derived from in-
ulin-like growth factor I receptor. MF-Nef was de-
igned to translate from polyribosomes in the ER,
ransported to the cell surface, and anchored to the
ytoplasmic leaflet through the transmembrane do-
ain. We assessed the ability of three Nef expression
orms to down-modulate cell surface expression of
D4 receptor because this function is conserved for
oth HIV-1 and SIV Nef proteins (Ratner et al., 1995;
rono, 1995). All expression forms of Nef reduced the
D4 expression as measured by FACS analysis (data
ot shown), suggesting that they are potentially bio-
FIG. 1. Expression of the native and membrane-targeted Nef pro-
eins. (A) Schematic representation of Nef expression constructs. The
ative Nef was constructed by fusion of human CD4 59-UT with the nef
ene derived from SIVmac239 or HIV-1 pNL4–3. MYR-Nef contains a
-Src myristylation signal peptide followed by the intact nef gene.
F-Nef expresses a membrane-targeted, nonmyristylated Nef. The nef
ene derived from SIV mac239 encodes 263 aa, and HIV-1 Nef encodes
06 aa. MYR, myristylation signal peptide derived from v-Src; SEC,
ouse preprotrypsin secretory leader; TM, transmembrane domain
rom IGFR. (B) Expression of the Nef proteins in transiently transfected
93T cells using LipofectAMINE reagent. The cell lysates were directly
mmunoblotted with anti-SIV Nef (left panel) or anti-HIV-1 Nef AG11
right panel). MAC indicates that the nef gene is from SIVmac239, and
L represents the nef protein derived from HIV-1 pNL4–3.ogical active forms.
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7DIFFERENTIAL PHOSPHORYLATION AND Nef/Lck ASSOCIATIONef interacts with Src family kinases
To assess the physical interactions of the Nef proteins
rom HIV-1 and SIV with the lymphocyte-specific Src
inase Lck, a transient cotransfection was performed
sing Nef expression vector and a wild-type Lck in 293T
ells. The SIV Nef proteins, including MF-NefMAC, MYR-
efMAC, and the native NefMAC, were coprecipitated with
ck, using anti-Lck for immunoprecipitation (Fig. 2A, top
anel, lanes 4–6, respectively). The SIV Nef proteins
ere not coprecipitated when a nonspecific control anti-
D3 was used for immunoprecipitation (Fig. 2A, top
anel, lanes 1–3). Similarly, all three forms of HIV-1 Nef
ere also found to associate with Lck as detected by the
n vivo association assay (Fig. 2A, bottom panel, lanes
–6). In Fig. 2A (bottom panel, lane 4), the native 27-kDa
ef band overlapped with IgG light chain. The interaction
f this native Nef protein with Lck is also shown in Fig. 3.
We next investigated the in vivo association of the Nef
roteins derived from both HIV-1 and SIV with these
hree other Src kinases: Hck, Lyn, and Fyn. Both kinases
re tagged with an influenza hemagglutinin (HA) epitope.
sp70-HA (heat shock protein 70) was used as a control.
s shown in Fig. 2B, HIV-1 Nef was coprecipitated with
ck, Lyn, or Fyn but not with Hsp70. Similarly, SIV Nef
as also coprecipitated with Hck and Fyn but not pre-
ipitated with Hsp-70. A weak interaction of SIV Nef and
yn was also detected (Fig. 2B, top panel). The amount of
ef protein precipitated by Hck was at least threefold
reater than that precipitated by Lyn (Fig. 2B), indicating
hat the Nef proteins have higher affinity for Hck than for
yn.
he in vivo interaction of Nef with Src kinases
equires membrane association
Because the Nef proteins are also present in cytoplas-
ic fraction in addition to the membrane fraction, we
ested the association of the non-membrane-bound Nef
ith Lck and Hck. By attaching a Flag epitope at the
-terminus of the native Nef, a nonmyristylated non-
embrane-targeted Nef (Flag-Nef) was generated (de-
icted in Fig. 3A). MF-NefNL or Flag-NefNL was cotrans-
ected with Lck or Hck into 293T cells followed by the in
ivo association assay. As demonstrated in Fig. 3B, only
he membrane-targeted Nef protein (MF-Nef) was copre-
ipitated with either Lck or Hck. The Flag-Nef was not
recipitated by Lck and also not by Hck in vivo. Similar
esults were obtained when SIV Nef was used (data not
hown).
he conserved core region of HIV-1 Nef is required
or association with the SH3 and SH2 domains of Lck
To further assess which specific domains of Lck me-
iate the association with Nef, recombinant GST-fusion
roteins, including GST-LckSH2, GST-LckSH3, and GST,
ere used for in vitro interaction assay. In Fig. 4A, the (FIG. 2. SIV and HIV-1 Nef proteins physically interact with Src family
inases in vivo. (A) The in vivo association assay was performed by a
ransient cotransfection of native NefMAC, MYR-NefMAC, or MF-NefMAC with
ck into 293T cells. The cellular extracts were precleared with normal
ouse serum and protein G agarose and immunoprecipitated with mouse
nti-CD3 (lanes 1–3) as a negative control or with mouse anti-Lck (lanes
–6). The immunoprecipitates were analyzed by immunoblotting using
nti-SIV Nef. Protein extracts from the transfected cells were directly
mmunoblotted with anti-SIV Nef (lanes 7–9). NefMAC, lanes 3, 6, and 9;
YR-NefMAC, lanes 2, 5, and 8; and MF-NefMAC, lanes 1, 4, and 7 (top panel).
he transient cotransfection of HIV-1 Nef and Lck expression plasmids
as performed using the procedure similar to the above. The cellular
xtracts were immunoprecipitated with anti-CD3 (lanes 1–3) or anti-Lck
lanes 4–6), followed by immunoblotting with anti-HIV-1 Nef (AG11). An
qual amount of cellular proteins was directly immunoblotted with AG11
lanes 7–9). NefNL, lanes 1, 4, and 7; MYR-NefNL, lanes 2, 5, and 8; and
F-NefNL, lanes 3, 6, and 9 (bottom panel). LC indicates IgG light chain;
C, for IgG heavy chain. Arrows 1–3 indicate MF-Nef, MYR-Nef, and the
ative Nef, respectively. (B) MF-NefNL or MF-NefMAC was cotransfected with
yn-HA, Hck-HA, Lyn-HA, or Hsp70-HA. The protein extracts were pre-
leared with normal rabbit serum and protein A beads, followed by immu-
oprecipitation using rabbit anti-HA. The precipitates were transferred to a
itrocellulose membrane and analyzed by immunoblot with anti-Flag M2
top panel). The membrane was stripped with 0.2 M glycine, pH 2.0, and
eblotted with mouse anti-HA (middle panel) to detect the expression of
yn, Hck, Lyn, and Hsp-70. The equal protein extracts were directly
mmunoblotted with anti-Flag M2 for detecting Nef expression levels
bottom panel). IP, immunoprecipitation.
N
l
G
e
s
N
N
t
v
w
t
c
l
7
a
N
m
t
N
f
c
D
L
t
m
s
N
N
i
c
t
c
t
p
d
l
S
b
L
f
t
N
p
d
t
a
a
T to Fig.
8 CHENG, HOXIE, AND PARKSef proteins prepared from transiently expressed cellu-
ar extracts were coprecipitated using GST-Lck SH3 or
ST-LckSH2 but not by GST. These data indicate that
ither the SH3 domain or the SH2 domain of Lck is
ufficient for the association with either HIV-1 Nef or SIV
ef in non-tyrosine-phosphorylated forms, because both
ef proteins transiently expressed in 293T cells were not
yrosine-phosphorylated (data not shown).
Mutagenesis was performed to generate HIV-1 Nef
ariants with internal deletions in the central core to test
hether these peptide sequences mediate Nef–Lck in-
eraction (Table 1). Selected peptide sequences in the
entral region that are conserved among HIV-1 Nef al-
eles and SIV Nef include NefDVPLR (amino acids [aa]
4–77), NefDILD (aa 109–111), NefDGPG (aa 130–132),
nd NefDKLVPV (aa 144–148). The wild-type Nef and
efDVPLR, which contains a deletion mutation of the
ajor PXXP motif within the core region, were coprecipi-
ated by GST-LckSH3 recombinant protein, but NefDILD,
efDGPG, and NefDKLVPV were not (Fig. 4B, top left). We
urther assessed several additional conserved aa in the
ore of HIV-1 Nef. The deletion of Y81K82, H89F90,
123W124, or F139G140 abolished the association with
ck, whereas deletion of G95G96 retained the associa-
ion of Nef with Lck (Fig. 4B, top right).
FIG. 3. Membrane association of Nef is required for the interaction w
nd non-membrane-targeted nonmyristylated Nef (Flag-Nef). (B) MF-Ne
he in vivo association assay was performed as described in legendThe associations of the native Nef and various Nef (utants of HIV-1 with Hck were also assessed. In con-
istency with previous reports, the PXXP motif of HIV-1
ef is essential for interaction with Hck, because
efDVPLR with mutations in the major PXXP motif abol-
shed the association with Hck (Fig. 4B, bottom left). The
onserved core of HIV-1 Nef appeared not to be essen-
ial for the interaction with Hck, because mutations of the
onserved peptides of Nef did not abolish the associa-
ion with Hck (Fig. 4, bottom right). Thus the interaction
atterns of Nef and Lck or Nef and Hck are apparently
ifferent, although some peptide sequences of Nef over-
ap.
IV Nef, but not HIV-1 Nef, is tyrosine-phosphorylated
y Lck
To examine the tyrosine-phosphorylation of Nef by
ck, the in vivo tyrosine-phosphorylation assay was per-
ormed by a transient cotransfection using a kinase ac-
ive form of Lck (LckCA) with MF-NefMAC or with MYR-
efNL. As shown in Fig. 5A (top panel), SIV Nef was
hosphorylated by Lck. In contrast, under identical con-
itions, HIV-1 Nef was not phosphorylated by Lck. The
yrosine-phosphorylation of SIV Nef requires the kinase
ctivity of Lck, because a kinase-deficient variant of Lck
and Hck. (A) Schematic structures of membrane-targeted Nef (MF-Nef)
lag-NefNL was cotransfected with either Lck or Hck-HA in 293T cells.
2.ith Lck
fNL or FLckKM) (Wange et al., 1996) did not phosphorylate the SIV
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9DIFFERENTIAL PHOSPHORYLATION AND Nef/Lck ASSOCIATIONef protein (Fig. 5A, right panel). Lck also phosphory-
ated the native SIV Nef and the MYR-NefMAC in a tran-
ient cotransfection of 293T cells (Fig. 5B, top panel). In
ddition, we observed that Flag-NefMAC was not phos-
horylated by Lck in vivo (data not shown), indicating that
he tyrosine-phosphorylation of SIV Nef requires its
embrane association.
he association of Nef and Lck is important for
nhanced HIV-1 replication in T-lymphocytes
Finally, we examined the functional relevance of the
ef-Lck association with Nef’s enhancement of viral rep-
ication. We selected several representative HIV-1 Nef
FIG. 4. The conserved core region of Nef is essential for interaction with
he SH3 and SH2 domains of Lck. (A) The SH3 or SH2 domain of Lck is
ufficient for the association with Nef. Equal amounts of cellular extracts
ere prepared from the transfected cells with either the native SIV Nef
rotein (left panel) or the native HIV-1 Nef (right panel) expressed in 293T
ells. The lysates were precleared with GST-coated beads followed by
ncubating with 4 mg of GST-fusion protein-coated beads (GST-LckSH3,
ST-Lck SH2, or GST alone) at 4°C for 2 h. The precipitates were analyzed
y immunoblotting with anti-SIV Nef (left panel) or with anti-HIV-1 Nef AG11
right panel). (B) The Nef proteins expressed in 293T cells, including the
ative HIV-1 Nef and the Nef mutants NefD74VPLR77, NefD109ILD111,
efD130GPG133, NefD144KLVPV148, NefDY81K82, NefDH89F90,
efDG95G96, NefDD123W124, and NefDF139G140, were incubated
ith GST-LckSH3-coated beads. The precipitates were immunoblotted
ith anti-Nef AG11 (top panel). The Nef protein levels were shown at
he middle panel. In addition, the native Nef and the Nef mutants as
hown above were transiently cotransfected with Hck-HA. The protein
xtracts were precleared and immunoprecipitated with anti-HA, fol-
owed by immunoblotting using anti-HIV-1 Nef (bottom panel).utants, including NefDVPLR, NefDILD, NefDGPG, andefDKLVPV, as well as the wild-type NefNL, and inserted
hese Nef fragments into the infectious DNA backbone of
IV-1 (pNL4-3) to replace the native nef locus. Infectious
iruses with various Nef mutants were generated by
ransient transfection of the proviral DNAs into 293T
ells, and these viruses were used to subsequently in-
ect the human T-lymphocyte line CEM X174. All four
utant viruses showed decreased levels of viral replica-
ion compared with the wild-type virus as quantified with
24 titer (Fig. 6). As shown earlier, NefDILD, NefDGPG,
nd NefDKLVPV did not associate with Lck, indicating
hat the Nef–Lck complex is likely to be necessary for the
nhanced viral replication in T cells. Intriguingly,
efDVPLR, which contains mutations in the major PXXP
otif, also showed a decreased ability to enhance viral
eplication. These data suggest that the Nef–Lck asso-
iation is necessary but not sufficient for this enhanced
eplication. Nef may require one domain for Lck associ-
tion and the PXXP motif for an optimal biological activity
n promoting viral replication.
DISCUSSION
HIV-1 Nef was coprecipitated with several cellular
roteins in T cells; Lck and CD4 were identified among
ef-associated cellular factors previously (Greenway et
l., 1995). However, a direct interaction of Nef and Lck
as not observed in subsequent reports (Moarefi et al.,
997; Saksela et al., 1995; Sawai et al., 1994). Instead,
wo groups demonstrated that Hck, a Src family tyrosine
inase closely related to Lck, binds directly to HIV-1 Nef
ith high affinity (Moarefi et al., 1997; Saksela et al.,
995). Mutational studies and crystal structure analysis
evealed that HIV-1 Nef associates with Hck via the
irect interaction of the proline-rich motif and the SH3
omain (Lee et al., 1995, 1996; Saksela et al., 1995).
ecause Hck is present in monocytes and B-lympho-
ytes and is not present in T cells, the biological signif-
cance of the direct Nef–Hck interaction remains unclear.
o further evaluate the association of Nef and Lck, Col-
TABLE 1
Internal Deletions of the Core Region of HIV-1 Nef
Plasmids Mutations
Nef Wild type
NefDVPLR Deletion VPLR (aa 74–77)
NefDILD Deletion ILD (aa 109–111)
NefDGPG Deletion GPG (aa 130–132)
NefDKLVPV Deletion KLVPV (aa 144–148)
NefDYK Deletion YK (aa 81–82)
NefDHF Deletion HF (aa 89–90)
NefDGG Deletion GG (aa 95–96)
NefDDW Deletion DW (aa 123–124)
NefDFG Deletion FG (aa 139–140)
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10 CHENG, HOXIE, AND PARKSette et al. (1996) and Greenway et al. (1996) reported a
irect interaction of Nef with Lck. They showed that HIV-1
ef is tyrosine-phosphorylated in Jurkat T cells and was
pecifically coprecipitated by the SH3 and SH2 domains
f Lck, and the PXXP motif of HIV-1 Nef was responsible
or interaction with Lck. In subsequent studies, Baur et
l. (1997) observed that a conserved amphipathic a-helix
n the N-terminus of Nef of HIV-1 and SIV is sufficient to
orm a complex with Lck and a cellular serine kinase.
his serine kinase can be distinguished from serine
inases p62/p72 identified by Sawai et al. (1994) and
resumably bridges Nef to Lck (Baur et al., 1997). In the
resent study, the PXXP motif of Nef is not sufficient for
ssociation with Lck. Mutagenesis analysis indicates
hat the conserved core of Nef is important for formation
f the Nef–Lck complex. In addition, the Nef variants with
utations in the core region but with an intact N-termi-
us abrogated the interaction with Lck. The N-terminal
-helix domain of Nef contains several basic aa such as
rginines similar to Src N-terminal domain. These basic
a are essential for membrane attachment because mu-
ations in this region abolish membrane association of
rc kinase (Resh, 1994). It appears that the N-terminal
FIG. 5. SIVmac239 Nef, but not HIV-1 Nef, is tyrosine-phosphorylate
YR-NefNL (1 mg) or MF-NefMAC (1 mg) with LckCA (kinase active Lck, 0.6
rom the transfected cells were immunoprecipitated with rabbit ant
mmunoblotting with combined anti-phosphotyrosine antibodies PY20 a
nd reblotted with anti-SIV Nef or AG11 (middle panel). The protein lev
he native NefMAC and MYR-NefMAC by LckCA were detected directl
otransfected 293T cells. The protein level of SIV Nef is indicated
utophosphorylated Lck is indicated with the upper arrow.-helix domain of Nef probably serves as an additional tignal for membrane targeting instead of serving as the
irect binding site for Lck. Our study shows that the
embrane attachment of Nef is essential for in vivo
nteraction with Lck.
Although overall amino acid sequence homology
hared by both Nef proteins from HIV-1 and SIV is about
8%, the two Nef proteins exhibit similar biological and
iochemical features (Ratner et al., 1995; Trono, 1995),
uggesting that they share a common peptide structure.
n addition to the conserved myristylation signal peptide,
he core region of Nef is conserved with peptide se-
uence homology of about 50–80% (Shugars et al., 1993).
everal peptide sequences distributed in four highly con-
erved blocks within the core region of Nef are crucial
or interacting with Lck and/or for maintaining protein
tability as demonstrated in the present study. The amino
cid sequence 130GPG133, Y81K82, H89F90, D123W124,
nd F139G140 of Nef is critical for the Nef–Lck associa-
ion. In addition, the HIV-1 Nef mutants with internal
eletions at 109ILD111 and 144KLVPV148 are expressed
t lower levels compared with that of wild-type HIV-1 Nef,
uggesting that these regions may be important for
aintaining Nef protein stability. It is not clear whether
ck. (A) The in vivo kinase assay was performed by cotransfection of
ckKM (kinase deficient Lck, 0.6 mg) into 293T cells. The cellular extracts
for MF-Nef or rabbit antiserum specific for HIV-1 Nef followed by
0 (top panel). The membrane was stripped with 0.2 M glycine (pH 2.0)
ck are indicated in the bottom panel. (B) Tyrosine-phosphorylation of
munoblotting using anti-phosphotyrosine antibodies in transiently
bottom panel. Arrow 1, MYR-NefMAC; arrow 2, native SIV Nef. Thed by L
mg) or L
i-Flag
nd 4G1
els of L
y by im
in thehese peptide sequences serve as the binding sites for
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11DIFFERENTIAL PHOSPHORYLATION AND Nef/Lck ASSOCIATIONck. It appears that Nef is associated with Lck via an
nteraction that is distinct from the Nef–Hck interaction.
n addition, the SH2 domain of Lck binds to HIV-1 Nef via
n atypical interaction, an observation consistent with
utartre et al. (1998). We also found that this SH2 domain
s mediating the interaction with SIV Nef that is not
pontaneously tyrosine-phosphorylated when expressed
n 293T cells. The mechanism of this type of interaction
s not currently understood. There probably is an inter-
ediate protein involved in the interaction between Nef
nd Lck. This putative connector might contain SH3- and
H2-binding domains mediating direct interaction with
ck; this possibility remains to be addressed. Neverthe-
ess, the conserved regions of Nef are necessary for
aintaining the integrity of the core structure that is
equired for formation of the Nef–Lck complex.
The tyrosine-phosphorylation of the SIV Nef protein
as been implicated to correlate with the pathogenesis
f simian AIDS reported by Du et al. (1995, 1996). SIV
Enef containing the putative SH2 binding domain re-
ulted in marked phosphorylation by v-Src and was as-
ociated with a rapid disease progression compared
ith wild-type SIVmac 239. We have demonstrated that a
inase-active Lck tyrosine-phosphorylates wild-type SIV-
ac239 Nef in the absence of the YE motif. Thus the
ollowing scenario may occur. Ligation of TCR and CD4–
ck complex in quiescent T cells leads to an immediate
ctivation of Lck upstream of the TCR-directed signaling
FIG. 6. The association of Nef and Lck is important for enhanced HI
1 ng (p24) of the wild-type virus NL-NefNL and the mutant viru
NefD144KLVPV148 according to the procedure described in Materials a
levels (ng/ml) from each virus-infected culture at several time points wathway (Glaichenhaus et al., 1992; Wange et al., 1996; Neil et al., 1996). Activated Lck can subsequently phos-
horylate SIV Nef; therefore, SIV Nef could serve as a
ubstrate of Lck and acquire a full activity through phos-
horylation for enhanced virus infectivity in vivo. A sec-
nd scenario may also occur. Regardless of tyrosine-
hosphorylation of Nef and alteration of the Lck kinase
ctivity, Nef may serve as an adapter that links Lck to
ther signaling molecules for modulation of cellular sig-
aling pathways. Nef has been previously found to as-
ociate with PKC-u, MAP kinase, c-Raf, serine kinases
62/p72, and p21-activated kinase (PAK), in addition to
rc kinases (Baur et al., 1994; Greenway et al., 1996;
odge et al., 1998; Nunn et al., 1996; Sawai et al., 1994;
mith et al., 1996). This evidence supports the possibility
hat Nef behaves as an adapter.
The finding that Nef increased IL-2 production and
nhanced virus replication in rhesus macaque T cells
urther supports that Nef modulates signaling cascades
Alexander et al., 1997). Because HIV-1 long terminal
epeat contains an IL-2-like enhancer, transcriptional
actors involved in T cell activation can positively regu-
ate viral replication (Cheng et al., 1998; Cullen, 1991;
awakami et al., 1988; Nabel et al., 1990; Siekevitz et al.,
987). This regulatory mechanism could be essential for
nitiating a productive viral replication at the early stage
fter viral entry. Finally, the differential tyrosine-phos-
horylation and the distinct association patterns of Nef
ith Src kinases suggest that although HIV-1 Nef and SIV
lication in human T cells. CEMX174 cells (1 3 106) were infected with
-NefD74VPLR77, NL-NefD109ILD111, NL-NefD130GPG133, and NL-
thods. The culture media were collected for p24 titer analysis. The p24
easured using ELISA.V-1 rep
ses NL
nd Me
ere mef share several biological functions, the precise mech-
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12 CHENG, HOXIE, AND PARKSnisms to exert these functions may differ. Future studies
f the detailed structural basis of the Nef–Lck complex
nd identification of the putative connectors could pro-
ide more information concerning the molecular mecha-
ism of Nef-enhanced viral replication.
MATERIALS AND METHODS
ell lines and antibodies
The 293T cells were maintained in DMEM with 10%
BS and 50 mg/ml gentamicin (GIBCO BRL, Grand
sland, NY). CEMX174 cells were cultured in RPMI
640 medium supplemented with 10% FBS and 50
g/ml gentamicin.
Polyclonal antibodies against HIV-1 Nef were obtained
rom AIDS Research and Reference Reagent Program
Bethesda, MD). Anti-Flag, anti-HA, and anti-Lck antibod-
es and GST-LckSH3 and GST-LckSH2 fusion proteins
ere obtained from Santa Cruz Biotechnology (Santa
ruz, CA). Anti-Flag M2 was from IBI (New Haven, CT).
nti-phosphotyrosine antibodies PY20 and 4G10 were
urchased from Transduction Laboratories (Lexington,
Y) and Upstate Biotechnology, Inc. (Lake Placid, NY)
espectively. FITC-labeled anti-CD4 was from Becton
ickinson (San Jose, CA).
To prepare mouse monoclonal anti-SIV Nef antibody,
he full length of SIVmac239 nef gene was amplified
sing PCR and cloned in pGEX4T-1 (Pharmacia, Uppsala,
weden) to generate GST-SIV Nef fusion protein. The
usion protein was purified by absorption to glutathione–
garose beads followed by 10% SDS–PAGE electro-
horesis. The fusion protein was eluted from the SDS–
AGE gel with PBS containing 0.1% SDS. The proteins
ere dialyzed with PBS. Using purified GST-SIV Nef fu-
ion protein, several mouse hybridoma cell clones pro-
ucing antibodies for SIV Nef were generated. The
ooled hybridoma culture supernatants were used for
mmunoblotting analysis.
lasmid DNA constructions and site-directed
utagenesis
The native Nef genes were derived from pNL4–3
HIV-1) and from pCMV/CD8-SIVmac239 Nef (Sawai et
l., 1994) using PCR with pfu DNA polymerase (Strat-
gene, La Jolla, CA). The PCR fragments were cloned
nto phEFneo vector, a modified version of pEF-BOS
Mizushima et al., 1990). MYR-Nef was generated by
usion of a fragment containing the 59-UT region and
yristylation sequence of the v-src gene with the nef
ene fragment. To generate a myristylation-deficient
embrane-targeted Nef, a transmembrane domain de-
ived from human insulin-like growth factor I receptor
as initially ligated with the nef gene fragment. Theused fragment was inserted into phEF/MFneo vector (a modified version of phEFneo) to generate phEF/MF-
efNL. A nonmyristylated and non-membrane-targeted
ef (Flag-Nef) was constructed by inserting the nef
ene into phEF/Flag vector. The internal deletion
utants of nef, NefD74VPLR77, NefD109ILD111,
efD130GPG133, NefD144KLVPV148, NefDY81K82,
efDH89F90, NefDG95G96, NefDD123W124, and
efDF139G140 were created by a PCR-based mu-
agenesis. SIVmac239 Nef expression vectors were
onstructed using the same approaches as HIV-1 Nef
o create the expression plasmids for native SIV Nef
NefMAC), MYR-NefMAC, or MF-NefMAC.
The cDNAs that express Fyn, Hck, Lyn, and Hsp-70
ere obtained from a human lymph node cDNA library
Edge BioSystems, Gaithersburg, MD) using PCR. All
f these cDNAs were cloned into the expression vec-
or pCEF with a C-terminal influenza HA epitope tag-
ing. Murine Lck cDNAs, including wild-type, kinase-
eficient, and kinase-active forms of Lck, were from
an Littman (New York University School of Medicine,
ew York, NY) and were subcloned into phEFneo vec-
or.
NA transfection, immunoprecipitation, and
mmunoblotting
Transfection of 293T cells was performed with
-well plates using LipofectAMINE reagent (GIBCO
RL) according to the manufacturer’s recommenda-
ion. Transiently transfected 293T cells were washed
nd resuspended in 4°C PBS. Cells were lysed in 0.4
l of RIPA buffer (50 mM Tris–Cl, pH 7.6, 100 mM NaCl,
% Nonidet P-40) containing 5 mg/ml leupeptin, 5
g/ml aprotinin, and 1 mM PMSF on ice for 30 min.
he cellular extracts were clarified by centrifugation at
4,000 rpm for 10 min at 4°C. Primary antibodies were
dded to the supernatants, followed by incubation for
h at 4°C. After incubation, protein A– or G–agarose
eads were added to the antibody–antigen mixture for
ncubation for 1 h on a rotator at 4°C. The beads were
ashed four times with the RIPA buffer, and 20 ml of
3 SDS loading buffer was then added to the beads.
he immunoprecipitates were boiled for 4 min, re-
olved on 12% SDS–PAGE, and transferred to a nitro-
ellulose membrane. The membrane was blocked with
% nonfat milk in T-TBS buffer (50 mM Tris–Cl pH 7.6,
00 mM NaCl, and 0.1% Tween 20) and subsequently
mmunoblotted with primary antibody diluted in T-TBS
uffer containing 5% nonfat milk at 37°C for 1 h. After
eing washed three times with T-TBS buffer, the mem-
rane was immunoblotted with secondary antibody
onjugated with horseradish peroxidase. The antigen–
ntibody complex was detected using the ECL systemAmersham, Arlington Heights, IL). The expressed pro-
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13DIFFERENTIAL PHOSPHORYLATION AND Nef/Lck ASSOCIATIONeins were also analyzed by direct immunoblotting
ithout the immunoprecipitation step.
etection of in vivo association of Nef
nd Src kinases
The 293T cells were transiently cotransfected with Nef
nd the expression plasmid for Hck-HA, Lyn-HA, or
sp70-HA. Similarly, the three different expression forms
f Nef from both HIV-1 and SIV were cotransfected with
he murine Lck expression plasmid. The transfected cells
ere collected 24 h posttransfection and were lysed in
he RIPA-containing protease inhibitors at 4°C for 30 min.
fter clarification by centrifugation, the cellular extracts
ere precleared with normal rabbit serum and protein A
eads, when rabbit antibody was used for immunopre-
ipitation or normal mouse serum and protein G beads if
ouse antibody is used, and followed by immunoprecipi-
ation using rabbit anti-HA or anti-Lck. The immunopre-
ipitates were analyzed by immunoblotting using anti-
lag (M2) or anti-Nef.
ssessment of in vitro association of Nef
nd Src kinases
Cellular extracts containing native Nef proteins ex-
ressed in 293T cells were prepared in the RIPA buffer
ontaining protease inhibitors. The cellular extracts were
recleared with GST-bound beads at 4°C for 2 h. GST-
ckSH3-, GST-LckSH2-, or GST-coated beads (4 mg
ach) were then added to the cellular extracts. Incuba-
ion was performed at 4°C for 2 h with rotation. After
ncubation, the beads were washed four times with RIPA
uffer, and the precipitates were resolved on 12% SDS–
AGE. Immunoblotting was performed using anti-SIV Nef
r anti-HIV-1 Nef.
n vivo tyrosine-phosphorylation assay
Nef expression plasmids and the kinase-active Lck
LckCA) or the kinase-mutant Lck (LckKM) were cotrans-
ected into 293T cells. The cellular extracts were pre-
ared in RIPA buffer containing cellular protease inhibi-
ors, including PMSF (1 mM), leupeptin (5 mg/ml), and
protinin (5 mg/ml), and the phosphatase inhibitor so-
ium vanadate (1 mM). After clarification by centrifuga-
ion, the cellular supernatants were immunoprecipitated
ith rabbit anti-Flag for immunoprecipitation of Flag-
agged SIV Nef or rabbit anti-HIV-1 Nef, followed by
mmunoblotting using combined anti-phosphotyrosine
Y20 and 4G10.
IV-1 infection assay
The Nef mutants of HIV-1, including the native NefNL,
efD74VPLR77, NefD109ILD111, NefD130GPG133, and
efD144KLVPV148, were inserted back to the infectious CNA (pNL4–3) at the BamHI and XhoI sites to generate
NL-NefNL, pNL-NefD74VPLR77, pNL-NefD109ILD111,
NL-NefD130GPG133, and pNL- NefD144KLVPV148. The
nfectious proviral DNAs were used for transient trans-
ection of 293T cells, and the viruses in the cell-free
edium were collected. The CEMX 174 cells (1 3 106)
ere infected with 1 ng of viruses (quantified as p24 titer
y ELISA) for 8 h, and the cells were washed three times
nd cultured in complete medium for 12 days. The cul-
ure medium was collected and applied for measurement
f p24 titer by ELISA.
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